DANBURY, Conn., and LAGRANGEVILLE, N.Y. (PRWEB)
October 22, 2019

As a complement to Nuvance Health’s August brand launch, the health system is now unveiling an advertising campaign that brings that brand to life.

“The advertising campaign is well-suited to the integration of Health Quest and Western Connecticut Health Network,” said Michael Samuelson, vice president of marketing and internal communications for Nuvance Health. “The advertisements depict Nuvance Health’s relentless drive to uncover new ways to help the community be healthy and stay healthy,” he said.

“We’re an organization comprised of imaginative people who never settle, attracting those who have the courage and agility to forge new and better paths together, the ingenuity to reinvent, the curiosity to ask questions and the empathy to truly listen to patients, families and community members,” Samuelson said.

Launching in mid-October, the campaign includes a television commercial, radio spots and print ads running throughout Connecticut and the Hudson Valley, in addition to billboards and digital display ads in shopping malls, transportation hubs, movie theaters and more.

Nuvance Health was formed April 1, when Western Connecticut Health Network and Health Quest Systems Inc. combined. The system’s seven hospitals and 2,600 doctors serve an area that encompasses about 1.5 million residents.

To view the television commercial or to listen to the radio advertisements, visit nuvancehealth.org/brandcampaign.

For more information about Nuvance Health, visit nuvancehealth.org.

CONTACTS

John Nelson, Director, Public and Community Affairs

O: (845) 554 1736 | C: (845) 240 4317 | john.nelson@nuvancehealth.org

Andrea Rynn, Director, Public & Government Relations

O: (203) 739 7919 | C: (203) 240 4072 Andrea.Rynn@nuvancehealth.org

About Nuvance Health

Nuvance Health is a family of award-winning nonprofit hospitals and healthcare professionals in the Hudson Valley and western Connecticut. Nuvance Health combines highly skilled physicians, state-of-the-art facilities and technology, and compassionate caregivers dedicated to providing quality care across a variety of clinical areas, including Cardiovascular, Neurosciences, Oncology, Orthopedics, and Primary Care.

Nuvance Health has a network of convenient hospital and outpatient locations — Danbury Hospital, New Milford Hospital, Norwalk Hospital and Sharon Hospital in Connecticut, and Northern Dutchess Hospital, Putnam Hospital Center and Vassar Brothers Medical Center in New York — plus multiple primary and specialty care physician practice locations, including The Heart Center, a leading provider of cardiology care, and two urgent care offices. Non-acute care is offered through various affiliates, including the Thompson House for rehabilitation and skilled nursing services, and the Home Care organizations. For more information about Nuvance Health, visit our website.

Share article on social media or email:

BALTIMORE (PRWEB)
October 23, 2019

A total of 27 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2019 “Top Docs” issue, representing 22 separate specialties, ranging from breast surgery to pediatrics to gastroenterology. Specifically (in alphabetical order):

Dr. John Campbell, Orthopedic Surgery: Foot & Ankle

Dr. Rebecca Cerrato, Orthopedic Surgery: Foot & Ankle

Dr. Joseph Costa, Intensivists/Critical Care

Dr. Charles Edwards, II, Spine Surgery

Dr. J. Lawrence Fitzpatrick, General Surgery

Dr. Neil B. Friedman, Breast Surgery

Dr. Bonnie Gerecke, Neurology, General; Neurology, Neuromuscular

Dr. Mary Harris, Gastroenterology: Inflammatory Bowel Disease

Dr. Scott Huber, Gastroenterology

Dr. Marc Hungerford, Orthopedic Surgery: Joint

Dr. Dwight Im, Gynecologic Oncology

Dr. Maria Jacobs, Radiation Oncology

Dr. Clifford Jeng, Orthopedic Surgery: Foot & Ankle

Dr. Sandy Kotiah, Hematology; Oncology-General

Dr. Michael Lansing, Pulmonary

Dr. Peter Ledakis, Hematololgy

Dr. Albert Polito, Pulmonary

Dr. Paul Lucas, Vascular Surgery

Dr. David Maine, Pain Management

Dr. David Riseberg, Oncology-General

Dr. Neil B. Rosenshein, Gynecologic Oncology

Dr. John-Paul Rue, Orthopedic Surgery: Sports Medicine

Dr. Armando Sardi, Surgical Oncology

Dr. Stephen Schenkel, Emergency Medicine

Dr. Lew Schon, Orthopedic Surgery: Foot & Ankle

Dr. Paul Thuluvath, Gastroenterology: Liver Disease

Dr. Ashanti Woods, General Pediatrics

In addition, Dr. Neil B. Rosenshein, Director, The Lya Segall Ovarian Cancer Institute at Mercy, is the physician featured on the November cover. The issue features an in-depth look at women’s health centers in the region with special emphasis on The Weinberg Center for Women’s Health & Medicine at Mercy in honor of the center’s 25th anniversary. Mercy urogynecologist Dr. R. Mark Ellerkmann, a past “Top Doc” winner, was among the issue’s group of select advisors.

Each Mercy physician was recognized as among the best in their respective fields. Recent additions to the Mercy medical staff, Dr. Lew Schon (Orthopedic Surgery: Foot & Ankle) and Dr. Michael Lansing (Pulmonary) were among those honored.

Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is a university-affiliated medical facility named a “Top Hospital” by U.S. News and World Report and has a national reputation for women’s health care. Mercy is home to the renowned Weinberg Center for Women’s Health and Medicine, now celebrating its 25th anniversary. For more information, visit Mercy’s website at http://www.mdmercy.com, visit MDMercyMedia on Facebook and Twitter, or call 1-800-MD-Mercy.

Share article on social media or email:

NEW YORK (PRWEB)
October 22, 2019

Three world-renowned environmental health researchers from the Institute for Exposomic Research at Mount Sinai have been awarded grants worth a total of $25 million from the National Institutes of Health (NIH) for the newly formed Human Health Environmental Assessment Resource (HHEAR). This program is dedicated to measuring all the environmental factors faced in people’s lives—a new science called “exposomics,” which is expected to yield important insights about disease processes and potential treatments.

The NIH established the HHEAR Laboratory Network Hub research network to facilitate novel research into children’s and adults’ environmental health. The goal of the consortium is to provide scientific researchers access to state-of–the-art laboratory analyses and advanced statistical data analyses of all the measurable environmental exposures that people face, so researchers can better understand why children and adults develop diseases like autism, asthma, heart disease, or even cancer. Additionally, HHEAR will make exposomic data publicly available and provide tools to allow the near-effortless pooling of the data across studies, so researchers around the world can better understand the effects of thousands of environmental exposures on health across people’s lifespans.

“This program is another giant step in the growth of our exposomics program. Mount Sinai is the only institution to be awarded multiple components of the large HHEAR research program with three large grants in exposomics, illustrating our leadership in the field,” said Robert Wright, MD, MPH, Ethel H. Wise Chair of Environmental Medicine and Public Health, and Co-Director of the Institute for Exposomic Research. “These three grants will further propel the Institute for Exposomic Research at Mount Sinai to the forefront of efforts to measure the exposome, the totality of environmental exposures from conception and throughout life. We believe studying the exposome is crucial to understanding how the complex mix of nutritional, chemical, and social environments affects health, disease, and development and to translate those findings into new strategies for prevention and treatment.”

The NIH awarded Dr. Wright funding for a HHEAR Laboratory Network Hub that studies mixtures of hundreds of exposures to substances. The lab will measure these exposures across all life stages to help NIH-funded researchers improve medical treatments and prevent diseases. The substances to be studied include lead, mercury, and other metals; plastics; pesticides; flame retardants; endocrine-disrupting chemicals; and tobacco metabolites, using state-of the art methods that take samples from sources including teeth, hair, and blood.

The NIH awarded Manish Arora, PhD, MPH, the Edith J. Baerwald Professor and Vice Chair of Environmental Medicine and Public Health, and Director of the Lautenberg Laboratory for Environmental Sciences, funding for a HHEAR Laboratory Hub that studies unidentified chemical exposures. This grant will use a suite of “omic” technologies to measure exposure to environmental chemicals and their metabolites as well as the internal response to those exposures. His grant works in tandem with Dr. Wright’s grant by discovering previously unknown chemical exposures that are then targeted for health research.

“Our team will build upon its highly successful work in creating novel methods to measure current and past chemical exposures in novel biological matrices and develop new assays that arise from HHEAR’s resources,” said Dr. Arora. “This project links highly experienced environmental health scientists with physicians, toxicologists, environmental researchers, chemists, exposure scientists, epidemiologists, and computer scientists to build the infrastructure and capacity to objectively measure the human exposome.”

Susan Teitelbaum, PhD, Research Professor of Environmental Medicine and Public Health, also received funding for the HHEAR Data Center which provides statistical analysis and data science expertise that is critical for advancing understanding of the complex “soup” of chemicals that affect people daily. The Data Center will incorporate scientific high-performance super-computing capabilities that Mount Sinai is known for to maximize the potential use and impact of environmental data within and outside of HHEAR, and will leverage the potential of big data to accelerate environmental health studies far beyond their original funded goals.

“This center has the potential to accomplish research that was previously thought unfeasible or too costly, through the use of recently developed big data techniques,” said Dr. Teitelbaum. “The HHEAR Data Center is critical to advancing the scientific community’s ability to examine the environment on an exposome scale.”

About The Institute for Exposomic Research

The Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai is the world’s first research institute devoted to the intensive study of the exposome, or the totality of environmental influences on human health. The mission of the Institute is to understand how the complex mix of nutritional, chemical, and social environments affect health, disease, and development later in life and to translate those findings into new strategies for prevention and treatment. For more information, visit http://icahn.mssm.edu/exposomics.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai’s vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools”, aligned with a U.S. News & World Report’s “Honor Roll” Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of top U.S. hospitals; it is one of the nation’s top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 “Best Hospitals” issue. Mount Sinai’s Kravis Children’s Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.